Technical Analysis for CTX - Crescita Therapeutics Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Crossed Above 50 DMA | Bullish | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Narrow Range Bar | Range Contraction | 6.90% | |
| Gapped Up | Strength | 6.90% | |
| Fell Below 20 DMA | Bearish | 8.77% | |
| Wide Range Bar | Range Expansion | 8.77% | |
| Gapped Down | Weakness | 8.77% | |
| Lower Bollinger Band Touch | Weakness | 8.77% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 2 days ago |
| Up 1% | 2 days ago |
| Lower Bollinger Band Support | 7 days ago |
| Gapped Down (Full) | 7 days ago |
| Down 2 ATRs | 7 days ago |
Get this analysis on your stocks daily!
- Earnings date: 2024-11-06
Crescita Therapeutics Inc. Description
Crescita Therapeutics Inc. is a drug development company. The Company owns products for treating medical conditions in dermatology and pain. It owns various drug delivery platforms, which include Durapeel and Foam technology to support the development of patented formulations that can deliver actives into or through the skin. It operates two business units: the Topical Products and Technology (TPT) Group and the Immunology Group. The TPT Group product, Pliaglis and other products are focused on dermatology and pain. Its product Flexicaine is in Phase II clinical stage and has therapeutic area in Tick-borne disease. Its product Ibuprofen Foam is in pre-clinical stage and has therapeutic area in Acute Pain. Its product Terbinafine is in pre-clinical stage and has therapeutic area in Onychomycosis. Its product Mical 1 is in pre-clinical stage and has therapeutic area in Psoriasis. Its product Mical 2 is in pre-clinical stage and has therapeutic area in Dermatological skin treatment.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Delivery Clinic Drug Pain Disease RTT Medical Specialties Skin Drugs Organ Systems Drug Development Immunology Psoriasis Dermatology Acute Pain Drug Delivery Onychomycosis Topical Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.73 |
| 52 Week Low | 0.36 |
| Average Volume | 26,859 |
| 200-Day Moving Average | 0.507 |
| 50-Day Moving Average | 0.602 |
| 20-Day Moving Average | 0.590 |
| 10-Day Moving Average | 0.584 |
| Average True Range | 0.019 |
| RSI (14) | 57.45 |
| ADX | 18.97 |
| +DI | 41.743 |
| -DI | 34.557 |
| Chandelier Exit (Long, 3 ATRs) | 0.564 |
| Chandelier Exit (Short, 3 ATRs) | 0.586 |
| Upper Bollinger Bands | 0.623 |
| Lower Bollinger Band | 0.557 |
| Percent B (%b) | 0.96 |
| BandWidth | 11.153 |
| MACD Line | -0.002 |
| MACD Signal Line | -0.004 |
| MACD Histogram | 0.0022 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.650 | ||||
| Resistance 3 (R3) | 0.647 | 0.633 | 0.645 | ||
| Resistance 2 (R2) | 0.633 | 0.626 | 0.635 | 0.643 | |
| Resistance 1 (R1) | 0.627 | 0.621 | 0.630 | 0.630 | 0.642 |
| Pivot Point | 0.613 | 0.613 | 0.615 | 0.615 | 0.613 |
| Support 1 (S1) | 0.607 | 0.606 | 0.610 | 0.610 | 0.598 |
| Support 2 (S2) | 0.593 | 0.601 | 0.595 | 0.597 | |
| Support 3 (S3) | 0.587 | 0.593 | 0.595 | ||
| Support 4 (S4) | 0.590 |
